RKI-057 functions by binding to the kinase domain of RIPK1, thereby blocking its enzymatic activity. RIPK1 is a key upstream mediator in the necroptotic pathway. When inhibited, the formation of the necroptosome complex (RIPK1-RIPK3-MLKL) is prevented, halting the downstream execution of necroptosis. This distinguishes it from apoptosis inhibitors, as it specifically targets programmed necrosis without directly affecting caspase-dependent pathways.

Classification: RKI-057 is a synthetic small molecule identified as a potent and selective inhibitor of Receptor-Interacting Protein Kinase 1 (RIPK1) . It is primarily used in preclinical research for studying necroptosis —a regulated form of necrotic cell death.

Size Chart

Measure your chest (A) and hips (B) following our indications. 

The reference measurement will always be the larger of the two (A or B).

Look in the chart to which size corresponds to that measurement.

Size chart
SizeReference measurements
 InchesCentimeters
2XS25.6 – 29.465 – 74
XS29.5 – 32.675 – 82
S32.7 – 36.183 – 91
M36.2 – 39.792 – 100
L39.8 – 42.8101 – 108
XL42.9 – 46.3109 – 117
2XL46.4 – 49.9118 – 126
3XL50 – 53127 – 134
4XL53.1 – 55.9135 – 142

Rki 057 [ INSTANT - 2025 ]

RKI-057 functions by binding to the kinase domain of RIPK1, thereby blocking its enzymatic activity. RIPK1 is a key upstream mediator in the necroptotic pathway. When inhibited, the formation of the necroptosome complex (RIPK1-RIPK3-MLKL) is prevented, halting the downstream execution of necroptosis. This distinguishes it from apoptosis inhibitors, as it specifically targets programmed necrosis without directly affecting caspase-dependent pathways.

Classification: RKI-057 is a synthetic small molecule identified as a potent and selective inhibitor of Receptor-Interacting Protein Kinase 1 (RIPK1) . It is primarily used in preclinical research for studying necroptosis —a regulated form of necrotic cell death. Rki 057